TSV-31766-58724 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-17
Dose 1 — Pfizer-BioNTech
2021-01-07
Registered in v-safe
2021-01-07
Dose 2 — Pfizer-BioNTech
2021-01-07
Health check-in — day 0, dose 2
Feeling: Fair · None

Adult check-in
2021-01-08
Survey response — days 1–6 daily, dose 2
MedDRA: Gastrointestinal pain — Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to work

Free text: Intestinal cramping

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-08
Report sent to call center — days 1–6 daily, dose 2
Be unable to work

1 call case(s)
2021-01-09
Survey response — days 1–6 daily, dose 2
MedDRA: Abdominal pain — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Abdominal cramping

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-09
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-10
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain, Redness, Swelling · None

Adult check-in
2021-01-11
Survey response — days 1–6 daily, dose 2
MedDRA: Feeling hot, Hyperhidrosis — Feeling: Good · Fever

Free text: Feeling hot/ sweaty

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-12
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-13
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-21
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-01-28
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-20
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-10
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-09-24
Dose 3 — Pfizer-BioNTech
2021-09-28
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None · Be unable to work or attend school

Adult check-in
2021-09-30
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-10-12
Survey response — day 14, dose 3
MedDRA: Heavy menstrual bleeding — Feeling: Fair · Be unable to do your normal daily activities

Free text: Heavier period

MedDRA releases: 2024-11 · check-in free text available
2021-10-24
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2021-12-26
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-09-24
Health check-in — 12 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-17	Pfizer-BioNTech
2	2021-01-07	Pfizer-BioNTech
3	2021-09-24	Pfizer-BioNTech	No

Call center

2 call center cases

2 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 2

2021-01-08

Systemic reaction (other): Intestinal cramping

2021-01-09

Systemic reaction (other): Abdominal cramping

2021-01-11

Systemic reaction (other): Feeling hot/ sweaty

Release 10 — day 14, dose 3

2021-10-12

Symptoms: Heavier period

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Heavy menstrual bleeding	·	·	✓
SRO	Abdominal pain	✓	✓	✓
SRO	Feeling hot	✓	✓	✓
SRO	Gastrointestinal pain	✓	✓	✓
SRO	Hyperhidrosis	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release